FDA Seeks to Enhance Manufacturing of Cell and Gene Therapies

BioPharm presents the Process Development Forum | Sponsored by GE Healthcare

New This Week on Process Development Forum

FDA Seeks to Enhance Manufacturing of Cell and Gene Therapies
More consistent and reliable production processes are critical for advancing innovative treatments.
(See Article)

Ensuring Viral Safety of Viral Vaccines and Vectors
Viral vaccines and viral vectors used in biotherapeutic applications carry the risk of microbial contamination, which must be addressed.
(Read Article)

Generate an Automated Purification Protocol in Three Steps Using Predefined Methods
Tied to your protein purification system during manual runs? Learn how to get started with automated chromatography using predefined methods and add three simple steps.
(See Article)

How to Determine Dynamic Binding Capacity (DBC) of Chromatography Resins
How to determine the DBC yourself to screen for the best resin and running conditions for your specific protein.
(Read Article)

Process Development Forum Topic Spotlight

QbD: Developing an Efficient Adenovirus Downstream Purification Process

Biosimilars: A Scalable Adenovirus Production Process

HTPD: Utilization of Mechanistic Modeling to Improve Process Development

Process Development: Queue Up Your Chromatography Steps

GO TO: Process Development Forum
Join the Conversation on LinkedIn



Questions for 2018 Like what you read? Want to see more of something in particular? Let us know what topics are on your mind and what you'd like to see more of in 2018.